Program improves sun protection practices among children of melanoma survivors
10/08/2013
Children of melanoma survivors were more likely to wear hats and re-apply sunscreen after receiving a multi-media informational program designed specifically for them. These new findings were included in research published in the journal of Cancer Epidemiology, Biomarkers and Prevention - a publication of the American Association for Cancer Research. A team of researchers led by Ellen R...
Discovery of new therapeutic agents may benefit leukemia patients
10/08/2013
An Indiana University cancer researcher and his colleagues have discovered new therapeutic targets and drugs that may someday benefit people with certain types of leukemia or blood cancer. Reuben Kapur, Ph.D...
Little-explored regions of genome reveals dozens of potential cancer triggers
10/08/2013
A massive data analysis of natural genetic variants in humans and variants in cancer tumors has implicated dozens of mutations in the development of breast and prostate cancer, a Yale-led team has found. The newly discovered mutations are in regions of DNA that do not code for proteins but instead influence activity of other genes...
Moderate activity linked to lower breast cancer risk
10/08/2013
A large new American Cancer Society study adds to increasing evidence that physical activity reduces the risk of breast cancer in postmenopausal women. Researchers say moderate recreational activity was associated with a 14 percent lower risk and high physical activity with a 25 percent lower risk of breast cancer compared to women who were active at the lowest level...
Use of post-operative blood clot rate as measure of hospital quality may be flawed
10/07/2013
A new study published by JAMA questions using the rate of postoperative blood clots as a hospital quality measure. The study is being released early online to coincide with the American College of Surgeons 2013 Annual Clinical Congress. The study examined whether surveillance bias (i.e...
Judy C. Boughey, M.D., Kelly K. Hunt, M.D., and colleagues for the Alliance for Clinical Trials in Oncology conducted a study to determine the false-negative rate of sentinel lymph node surgery in patients with node-positive breast cancer receiving chemotherapy before surgery...
Use of post-operative blood clot rate as measure of hospital quality may be flawed
10/07/2013
A new study published by JAMA questions using the rate of postoperative blood clots as a hospital quality measure. The study is being released early online to coincide with the American College of Surgeons 2013 Annual Clinical Congress. The study examined whether surveillance bias (i.e...
Zilico's cervical cancer diagnostic device lands CE Mark
10/07/2013
Zilico Ltd has received EC certification from its Notified Body for its cervical cancer diagnostics device, ZedScan I. The UK company's ground-breaking system offers quicker and more accurate detection of cervical neoplasia in real-time, enabling clinicians to improve patient management. The ZedScan I system is used alongside colposcopy on women identified with an abnormal smear result...
Cornerstone Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, has announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to CPI-613, the Company's lead Altered Energy Metabolism Directed (AEMD) drug candidate, for the treatment of myelodysplastic syndrome (MDS)...
Zilico's cervical cancer diagnostic device lands CE Mark
10/07/2013
Zilico Ltd has received EC certification from its Notified Body for its cervical cancer diagnostics device, ZedScan I. The UK company's ground-breaking system offers quicker and more accurate detection of cervical neoplasia in real-time, enabling clinicians to improve patient management. The ZedScan I system is used alongside colposcopy on women identified with an abnormal smear result...